Memorial Sloan-Kettering Cancer Center

138 results found.

Advanced Stage Head and Neck Cancer Clinical Trial using Quality of Life Questionaires & Interview: EORTC QLQ C-30, EORTC QLQ H&N-35, Health Behaviors, Subjective Significance Questionnaire, Qualitative Assessment

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- RECONSTRUCTIVE SURGERY For Head And Neck Cancer Patients: A Prospective Analysis Of Quality Of Life And Symptom Relief.
Quality of Life Questionaires & Interview: EORTC QLQ C-30, EORTC QLQ H&N-35, Health Behaviors, Subjective Significance Questionnaire, Qualitative Assessment

Breast Cancer Clinical Trial using Fluorestradiol (FES); PET/CT Imaging

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status.
Fluorestradiol (FES); PET/CT Imaging

Isolated Chemotherapy-induced Thrombocytopenia Clinical Trial using romiplostim,; Control cohort

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Randomized Open Label Phase II Study of Romiplostim Versus Observation for Chemotherapy Induced Thrombocytopenia.
romiplostim,; Control cohort

Brain Cancer Clinical Trial using Diffusion kurtosis imaging (DKI)

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Assessment of Early Response by Diffusion Kurtosis Imaging in Patients With Brain Metastasis.
Diffusion kurtosis imaging (DKI)

Ovarian Cancer, Fallopian Tubes Cancer, or Peritoneal Cancer Clinical Trial using Secondary Cytoreductive Surgery; Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC); platinum-based systemic chemotherapy postoperatively

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- A Phase II Randomized Study: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Secondary Cytoreductive Surgery; Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC); platinum-based systemic chemotherapy postoperatively

Head and Neck Cancer Clinical Trial using Flexible Fiber-based CO2 Laser, Quality of Life forms; electrocautery resection and quality of life forms

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Flexible Fiber-based CO2 Laser Versus Monopolar Cautery for Resection of Benign, Pre-malignant And Malignant Oral Cavity Lesions: A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery.
Flexible Fiber-based CO2 Laser, Quality of Life forms; electrocautery resection and quality of life forms

Head and Neck Cancers Clinical Trial using Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes.
Cerenkov emissions from the PET tracer 18F-FDG and the radiotherapeutic 131I

Multiple Myeloma Clinical Trial using Pomalidomide; stem cell; Dexamethasone; Clarithromycin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Autologous Stem Cell Transplant With Pomalidomide (CC-4047r) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma: A Phase 2 Open-Label Randomized Study by Tristate Consortium.
Pomalidomide; stem cell; Dexamethasone; Clarithromycin

Leukemia, or Acute Lymphoblastic Leukemia Clinical Trial using gene-modified T cells targeted to B-ALL tumor cells

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase I Trial of Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19.
gene-modified T cells targeted to B-ALL tumor cells

Appendix Cancer, or Colorectal Cancer Clinical Trial using Cytoreductive Surgery; HIPEC with Mitomycin-C; EPIC with FUDR and Leucovorin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Single-center, Randomized Phase II Trial of Early Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis.
Cytoreductive Surgery; HIPEC with Mitomycin-C; EPIC with FUDR and Leucovorin

Bladder Cancer Clinical Trial using Gemcitabine; Carboplatin; Panitumumab; radical cystectomy

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.
Gemcitabine; Carboplatin; Panitumumab; radical cystectomy

Prostate Cancer Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Molecular Studies and Clinical Correlations in Human Prostatic Disease.

Vaginal Cancer Clinical Trial using QOL

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Immediate Vaginal Reconstruction Following Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function.
QOL

Pain Clinical Trial using Dexmedetomidine; Placebo

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- A Double-Masked Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Video-Assisted Thoracic Surgery.
Dexmedetomidine; Placebo

Breast Cancer Clinical Trial using MAB HER 2 (HERCEPTIN)

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity.
MAB HER 2 (HERCEPTIN)

Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individual With Cancer.

Breast Cancer Survivor Clinical Trial using manualized group intervention; standardized, manualized group intervention

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Development of Group Interventions for Breast Cancer Survivors.
manualized group intervention; standardized, manualized group intervention

Non-cancer Affected Volunteers Clinical Trial using Saliva or Blood samples

Memorial Sloan-Kettering Cancer Center - Recruiting 60 years or older.
- Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging.
Saliva or Blood samples

Light Chain Deposition Disease (LCDD or MIDD), Light Chain and He Clinical Trial using Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Pilot Study of Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis.
Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone

Aplastic Anemia, Leukemia, or Myelodysplastic Syndrome Clinical Trial using Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.; CliniMACS device

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine.
Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.; CliniMACS device

Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Perito Clinical Trial using Narrow Band Imaging (NBI)

Memorial Sloan-Kettering Cancer Center - Recruiting 19 years or older.
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive.
Narrow Band Imaging (NBI)

Cancer Clinical Trial using questionnaire administration followed by cognitive interviews

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Linguistic Validation of the Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
questionnaire administration followed by cognitive interviews

Metastatic Transitional Cell Carcinoma of the Urothelium Clinical Trial using Buparlisib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium.
Buparlisib

For New York State Registered Family Practitioners and Internal M Clinical Trial using in-depth, semi-structured interviews

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Building a Network of Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations.
in-depth, semi-structured interviews

Pancreatic Ductal Adenocarcinoma Clinical Trial using The risk assessment questionnaire; Blood specimens; tumor tissue samples will be requested

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma.
The risk assessment questionnaire; Blood specimens; tumor tissue samples will be requested

Metastatic Castration Sensitive Prostate Cancer Clinical Trial using Degarelix; Ipilimumab; Radical Prostatectomy

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase 2 Study Combining Ipilimumab and Degarelix With Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer.
Degarelix; Ipilimumab; Radical Prostatectomy

Leukemia Clinical Trial using therapeutic autologous lymphocytes; cyclophosphamide

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase I/IIa Trial For The Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19.
therapeutic autologous lymphocytes; cyclophosphamide

Gastroesophageal Junction Adenocarcinoma, or Gastric Cancer Clinical Trial using Docetaxel, Leucovorin, Fluorouracil, Cisplatin; Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Patients With Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma.
Docetaxel, Leucovorin, Fluorouracil, Cisplatin; Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen

Mesothelioma Clinical Trial using Pemetrexed + Cisplatin or Carboplatin AUC=5 Pleurectomy/decortication (if feasible) Intensity Modulated Radiation Therapy

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Toxicity Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma..
Pemetrexed + Cisplatin or Carboplatin AUC=5 Pleurectomy/decortication (if feasible) Intensity Modulated Radiation Therapy

Gastric Cancer, or Pancreatic Cancer Clinical Trial using questionnaire, Blood specimens

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Gastroenteropancreatic and Unknown Primary Neuroendocrine Registry A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors.
questionnaire, Blood specimens

Breast Cancer, Prostate Cancer, Lung Cancer, Lymphoma Cancer, or Clinical Trial using group intervention and questionnaires; individual phone intervention and questionnaires

Memorial Sloan-Kettering Cancer Center - Recruiting 70 years or older.
- Pilot of a Geriatric Group Psychoeducational Intervention for Elderly Patients With Cancer.
group intervention and questionnaires; individual phone intervention and questionnaires

Prostate Cancer Clinical Trial using Abiraterone acetate; Abiraterone acetate plus degarelix; Degarelix

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase 2, Randomized, 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy.
Abiraterone acetate; Abiraterone acetate plus degarelix; Degarelix

Breast Cancer, or Endometrial Cancer Clinical Trial using HLA vaginal gel (HyaloGYNr),; questionnaires

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Single-Arm Clinical Trial Investigating the Feasibility of a Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms.
HLA vaginal gel (HyaloGYNr),; questionnaires

Melanoma Clinical Trial using LGX818

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase 2 Trial of the BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation.
LGX818

Neuroblastoma, or Sarcoma Clinical Trial using Cyclophosphamide, Topotecan, and Bevacizumab

Memorial Sloan-Kettering Cancer Center - Recruiting N/A to 21 years.
- A Phase II Trial of Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma.
Cyclophosphamide, Topotecan, and Bevacizumab

Leukemia Clinical Trial using cyclophosphamide; modified T cells

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase I Trial of Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab.
cyclophosphamide; modified T cells

Brain Cancer Clinical Trial using preoperative fMRI. DTI and DSI with tractography

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Using Functional MRI and Diffusion Tensor Imaging of the Motor and Language Pathways to Optimize Brain Tumor Resection.
preoperative fMRI. DTI and DSI with tractography

Renal Cancer Clinical Trial using 124IcG250

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Pilot Trial To Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma.
124IcG250

Leukemia, or Myelodysplastic Syndrome Clinical Trial using ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Phase I Trial of Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies.
ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195

Head and Neck Cancer, or Squamous Cell Cancer Clinical Trial using Afatinib, Ribavirin, and weekly carboplatin/paclitaxel

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase I Study of Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC).
Afatinib, Ribavirin, and weekly carboplatin/paclitaxel

Malignant Pleural Mesothelioma (MPM), Choroidal Nevus, Primary Uv Clinical Trial using tumor specimens

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Clinical and Histopathologic Characteristics of BAP1 Mutations.
tumor specimens

EGFR-Mutant Lung Cancer Clinical Trial using erlotinib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase 1 Trial of Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer.
erlotinib

Brain Metastases Clinical Trial using 18F-FCH PET Scan

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases.
18F-FCH PET Scan

Hereditary Nonpolyposis Colorectal Cancer, or Colon Cancer Clinical Trial using questionnaires, telephone interview, optional tube of blood drawn; questionnaires, telephone interview and optional tub of blood drawn

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients.
questionnaires, telephone interview, optional tube of blood drawn; questionnaires, telephone interview and optional tub of blood drawn

Leukemia, Myelodysplastic Syndrome, or Lymphoma Clinical Trial using CliniMACS Fractionation system (Arm A); CliniMACS Fractionation system (Arm B)

Memorial Sloan-Kettering Cancer Center - Recruiting 2 years to 70 years.
- Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies.
CliniMACS Fractionation system (Arm A); CliniMACS Fractionation system (Arm B)

Cancer Patients First-ever Acute Ischemic Stroke Clinical Trial using Enoxaparin; Aspirin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 85 years.
- A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke.
Enoxaparin; Aspirin

Non-Hodgkin's Lymphoma Clinical Trial using Carmustine; Etoposide; Cytarabine; Melphalan; Pegfilgrastim; 19-28z T CELLS; Autologous Stem Cell Transplantation

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase I Trial of High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma.
Carmustine; Etoposide; Cytarabine; Melphalan; Pegfilgrastim; 19-28z T CELLS; Autologous Stem Cell Transplantation

Thyroid Cancer Clinical Trial using IMRT; DWI MRI

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer.
IMRT; DWI MRI

Gastric Cancer Clinical Trial using questionnaires

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Early Onset and Familial Gastric Cancer Registry.
questionnaires

Melanoma Clinical Trial using Ipilimumab, Melphalan and Dactinomycin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Trial of The Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity.
Ipilimumab, Melphalan and Dactinomycin

Leukemia Clinical Trial using allogeneic hematopoietic stem cell transplantation; CliniMACS

Memorial Sloan-Kettering Cancer Center - Recruiting N/A to 75 years.
- Randomized Phase II Trial of Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation.
allogeneic hematopoietic stem cell transplantation; CliniMACS

Squamous Cell Carcinoma of the Oropharynx Clinical Trial using questionnaire and semi-structured interviews

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Surviving Oropharynx Cancer: Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life.
questionnaire and semi-structured interviews

Head and Neck Cancer, or Prostate Cancer Clinical Trial using MRI scanner with sequence

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers.
MRI scanner with sequence

Multiple Myeloma Clinical Trial using busulfan; melphalan; fludarabine; anti-thymocyte globulin (ATG); a T cell depleted stem cell transplant

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years to 69 years.
- A Phase I Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma.
busulfan; melphalan; fludarabine; anti-thymocyte globulin (ATG); a T cell depleted stem cell transplant

Localized Stage I-III Esophageal Cancer, or Gastroesophageal Junc Clinical Trial using nutritional and functional assessments

Memorial Sloan-Kettering Cancer Center - Recruiting 65 years or older.
- A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer.
nutritional and functional assessments

Advanced Solid Tumor Diseases Clinical Trial using Individual Meaning-Centered Psychotherapy (IMCP); standard Individual Supportive Psychotherapy (ISP); enhanced usual care (EUC)

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- A Randomized Controlled Trial of Individual Psychosocial Interventions for Cancer Patients.
Individual Meaning-Centered Psychotherapy (IMCP); standard Individual Supportive Psychotherapy (ISP); enhanced usual care (EUC)

Acute Promyelocytic Leukemia Clinical Trial using Tretinoin and Arsenic Trioxide

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy.
Tretinoin and Arsenic Trioxide

Lung Cancer Clinical Trial using LDE225, Etoposide and Cisplatin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase I Trial of the Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC).
LDE225, Etoposide and Cisplatin

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome, or Non-Hodg Clinical Trial using Palifermin; Lupron; without the addition of palifermin or Lupron; peripheral blood stem cell transplantation

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 60 years.
- An Open Label Randomized Phase II Study of Palifermin With or Without Leuprolide Acetate Versus Control for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.
Palifermin; Lupron; without the addition of palifermin or Lupron; peripheral blood stem cell transplantation

Metastatic Colorectal Cancer Clinical Trial using combination panitumumab and vemurafenib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Pilot Study of Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer.
combination panitumumab and vemurafenib

Support of the Family as a Caregiving System Clinical Trial using Working with the Caregiving Family (WCF) training

Memorial Sloan-Kettering Cancer Center - Recruiting 12 years or older.
- Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting.
Working with the Caregiving Family (WCF) training

Esophageal Cancer, or Gastric Cancer Clinical Trial using Regorafenib; 5-Fluorouracil; Leucovorin; Oxaliplatin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer.
Regorafenib; 5-Fluorouracil; Leucovorin; Oxaliplatin

Neoplasms Clinical Trial using buccal swabs and obtaining peripheral blood

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Oncology/Bone Marrow Transplantation Patients.
buccal swabs and obtaining peripheral blood

Breast Cancer Clinical Trial using Dasatinib and Paclitaxel

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 90 years.
- A Phase I-II Study of Dasatinib in Combination With Weekly Paclitaxel for Patients With Metastatic Breast Carcinoma.
Dasatinib and Paclitaxel

Neuroblastoma, or Bone Marrow, Sympathetic Nervous System Clinical Trial using cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma.
cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8

Urothelial Cancer, Renal Pelvis Cancer, Ureter Cancer, or Bladder Clinical Trial using saliva sample and questionaire; saliva sample, questionaire

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Familial and Atypical Urothelial Cancer Registry.
saliva sample and questionaire; saliva sample, questionaire

Neuroblastoma Clinical Trial using adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH

Memorial Sloan-Kettering Cancer Center - Recruiting N/A to 21 years.
- Phase I/II Trial of a Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral á-glucan for High-Risk Neuroblastoma.
adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH

Bladder Cancer Clinical Trial using external radiation therapy with gemcitabine

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy.
external radiation therapy with gemcitabine

Solid Tumors, or Relapsed/Refractory Sarcomas Clinical Trial using Vorinostat and Etoposide

Memorial Sloan-Kettering Cancer Center - Recruiting 4 years to 21 years.
- A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors.
Vorinostat and Etoposide

Acute Lymphocytic Leukemia Clinical Trial using Biological/Genetically Modified T cells

Memorial Sloan-Kettering Cancer Center - Recruiting N/A to 19 years.
- A Phase I Dose Escalation Trial Using In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the B-Cell Specific Antigen CD19 Positive Residual Or Relapsed Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation.
Biological/Genetically Modified T cells

Germ Cell Cancer Clinical Trial using Endo-PAT2000 testing

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Pilot Study Measuring Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls.
Endo-PAT2000 testing

Multiple Myeloma Clinical Trial using lenalidomide

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance.
lenalidomide

Bladder Cancer Clinical Trial using Gemcitabine and Pazopanib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of Gemcitabine and Pazopanib in Chemotherapy Na‹ve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy.
Gemcitabine and Pazopanib

Confirmed Diagnosis of ß-thalassemia Major Clinical Trial using Autologous CD34+ cells transduced with TNS9.3.55

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase I Clinical Trial for the Treatment of ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene.
Autologous CD34+ cells transduced with TNS9.3.55

Solid Malignancy, or Lymphoma Clinical Trial using [18F] 4-L-Fluoroglutamine (2S,4R)

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years to 90 years.
- A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R).
[18F] 4-L-Fluoroglutamine (2S,4R)

Basal Cell Carcinoma Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins.

Cetuximab-induced Papulopustular (Acneiform) Rash Who Have, or Me Clinical Trial using Topical Dapsone 5% Gel; Moisturizer; oral antibiotics

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase III Randomized Double-blind Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT.
Topical Dapsone 5% Gel; Moisturizer; oral antibiotics

Lymphoma, Leukemia, Multiple Myeloma, Colon Cancer, or Renal Canc Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders.

Rectal Cancer, or Rectum Clinical Trial using questionnaires; CSI-SH- Cancer Survivorship Intervention

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- The Sexual Health of Rectal Cancer Patients: A Pilot Study.
questionnaires; CSI-SH- Cancer Survivorship Intervention

Breast Cancer Clinical Trial using questionaire, blood or saliva sample

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 54 years.
- Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer.
questionaire, blood or saliva sample

Uveal Melanoma Clinical Trial using RAD001 (Everolimus) and Pasireotide (SOM230) LAR

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma.
RAD001 (Everolimus) and Pasireotide (SOM230) LAR

Breast Cancer Clinical Trial using pertuzumab in combination with trastuzumab and paclitaxel

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer.
pertuzumab in combination with trastuzumab and paclitaxel

Breast Cancer Clinical Trial using BRCA testing and questionnaire assessments

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 50 years.
- Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer.
BRCA testing and questionnaire assessments

Sarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Clinical Trial using Gemcitabine and Docetaxel in Combination with Pazopanib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase IB/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS).
Gemcitabine and Docetaxel in Combination with Pazopanib

Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peri Clinical Trial using Acute Normovolemic Hemodilution

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 69 years.
- A Pilot Study of Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer.
Acute Normovolemic Hemodilution

Cervical Cancer Clinical Trial using DCE-MRI and 18F-FMISO PET

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer.
DCE-MRI and 18F-FMISO PET

Cancer Free Women Clinical Trial using questionnaire

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- Epidemiology of MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk.
questionnaire

Breast Cancer With Chronic Lymphedema Clinical Trial using Acupuncture; Wait-list

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Acupuncture for Chronic Lymphedema: A Randomized Wait-list Controlled Trial.
Acupuncture; Wait-list

Hodgkin Lymphoma Clinical Trial using Brentuximab vedotin (SGN-35); Doxorubicin HCL; Vinblastine Sulfate; Dacarbazine; Involved-Site Radiation Therapy (ISRT); Interim PET

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 60 years.
- A Pilot Study of Brentuximab Vedotin Combined With AVD Chemotherapy and 30 Gray Involved-Site Radiotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma.
Brentuximab vedotin (SGN-35); Doxorubicin HCL; Vinblastine Sulfate; Dacarbazine; Involved-Site Radiation Therapy (ISRT); Interim PET

Advanced Gastrointestinal Cancer Clinical Trial using single pilot interview; goals-of-care (GOC) video; goals-of-care (GOC) video and narrative question; usual care

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients.
single pilot interview; goals-of-care (GOC) video; goals-of-care (GOC) video and narrative question; usual care

Brain and Central Nervous System Tumors, Neuroblastoma, or Sarcom Clinical Trial using iodine I 131 monoclonal antibody 8H9

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Phase I Study Of Intrathecal Radioimmunotherapy Using I-8H9 For Central Nervous System/Leptomeningeal Neoplasms.
iodine I 131 monoclonal antibody 8H9

Osteosarcoma Clinical Trial using Tissue Procurement

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors.
Tissue Procurement

Adrenal Cortical Cancer, Brain Cancer, Breast Cancer, CNS Cancer, Clinical Trial using Proton-decoupled 31P MRS at 1.5T; 1H Spectroscopy at 1.5T and 3T

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Spectroscopy With Surface Coils and Decoupling.
Proton-decoupled 31P MRS at 1.5T; 1H Spectroscopy at 1.5T and 3T

Prostate Cancer Clinical Trial using [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer.
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone

Skin Cancer Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 10 years or older.
- In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin.

Total Exenteration,, Anterior or Posterior Pelvic Exenteration, G Clinical Trial using questionnaires/interviews

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration.
questionnaires/interviews

Esophageal Cancer, Bile Duct Neoplasms, Gastric Cancer, Liver Can Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites..

Multiple Myeloma Clinical Trial using busulfan, melphalan and fludarabine

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years to 70 years.
- A Trial of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions for Patients With Relapsed or High-Risk Multiple Myeloma.
busulfan, melphalan and fludarabine

Non-Small Cell Lung Cancer Clinical Trial using Bortezomib; Acyclovir

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase 2 Trial of Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D.
Bortezomib; Acyclovir

Neuroblastoma Clinical Trial using 3F8 Monoclonal Antibody Combined with Interleukin-2

Memorial Sloan-Kettering Cancer Center - Recruiting 13 Months or older.
- Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors.
3F8 Monoclonal Antibody Combined with Interleukin-2

Lymphoma Clinical Trial using cyclophosphamide; cyclosporine; fludarabine phosphate; gemcitabine hydrochloride; ifosfamide; mechlorethamine hydrochloride; melphalan; methotrexate; mycophenolate mofetil; prednisone; procarbazine hydrochloride; vincristine sulfate; vinorelbine tartrate; allogeneic bone marrow transplantation; allogeneic hematopoietic stem cell transplantation; nonmyeloablative allogeneic hematopoietic stem cell transplantation; peripheral blood stem cell transplantation; umbilical cord blood transplantation; total-body irradiation

Memorial Sloan-Kettering Cancer Center - Recruiting 13 years to 65 years.
- An Intention-to-Treat Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin Lymphoma.
cyclophosphamide; cyclosporine; fludarabine phosphate; gemcitabine hydrochloride; ifosfamide; mechlorethamine hydrochloride; melphalan; methotrexate; mycophenolate mofetil; prednisone; procarbazine hydrochloride; vincristine sulfate; vinorelbine tartrate; allogeneic bone marrow transplantation; allogeneic hematopoietic stem cell transplantation; nonmyeloablative allogeneic hematopoietic stem cell transplantation; peripheral blood stem cell transplantation; umbilical cord blood transplantation; total-body irradiation

Bladder Cancer Clinical Trial using Everolimus and Intravesical Gemcitabine

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase I/II Study of RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder.
Everolimus and Intravesical Gemcitabine

Head and Neck Cancer Clinical Trial using F-MISO PET scan

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients.
F-MISO PET scan

Breast Cancer Clinical Trial using AIM materials and assessments

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Attention and Interpretation Modification (AIM) for Fear of Breast Cancer Recurrence: An Intervention Development Study.
AIM materials and assessments

Acute Myeloid Leukemia, or Acute Lymphoblastic Leukemia Clinical Trial using WT1 peptide vaccine

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Trial of a WT-1 Analog Peptide Vaccine in Patients in Complete Remission (CR) From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL).
WT1 peptide vaccine

Prostate Cancer Clinical Trial using Fascial suturing; Lymph node template

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- A Randomized Trial of Modifications to Radical Prostatectomy.
Fascial suturing; Lymph node template

Breast Cancer Clinical Trial using survey web-based or telephone interview

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 64 years.
- Breast Cancer and the Workforce: Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life (BCW).
survey web-based or telephone interview

Breast Cancer, or Tobacco Dependence Clinical Trial using placebo; varenicline

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Treatment of Tobacco Dependence in Breast Cancer Patients: A Randomized Trial of Varenicline (Chantix).
placebo; varenicline

Prostate Cancer Clinical Trial using Prostate Biopsy, Focal Brachytherapy , Assessment of QOL

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy Early Stage, Low Volume in Prostate Cancer.
Prostate Biopsy, Focal Brachytherapy , Assessment of QOL

Lung Cancer Clinical Trial using pemetrexed plus cisplatin; vinorelbine and docetaxel

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Trial of Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN).
pemetrexed plus cisplatin; vinorelbine and docetaxel

Esophagogastric Cancer Clinical Trial using 89Zr-DFO-trastuzumab; PET imaging

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer.
89Zr-DFO-trastuzumab; PET imaging

Malignant Pleural Mesothelioma Clinical Trial using WT-1-vaccine Montanide + GM-CSF; Montanide adjuvant + GM-CSF

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Randomized Phase II Study of Adjuvant WT-1 Analog Peptide Vaccine in Patients With Malignant Pleural Mesothelioma (MPM) After Completion of Combined Modality Therapy.
WT-1-vaccine Montanide + GM-CSF; Montanide adjuvant + GM-CSF

Non-Hodgkin's Lymphoma, or Active Solid Malignancy Clinical Trial using PET Imaging using 124 IPUH71

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 90 years.
- PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study.
PET Imaging using 124 IPUH71

Hepatocellular Carcinoma Clinical Trial using Sorafenib; Doxorubicin

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Phase II Study of Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib.
Sorafenib; Doxorubicin

Invasive Breast Cancer Clinical Trial using Eucerin; Mometasone Furoate 0.1%

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation:A Randomized Trial, Double Blind Trial.
Eucerin; Mometasone Furoate 0.1%

Prostate Cancer Clinical Trial using blood draw

Memorial Sloan-Kettering Cancer Center - Recruiting 30 years or older.
- Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence.
blood draw

Thymoma, Thymic Carcinoma, or Clinical Masaoka Stage II-IVA Clinical Trial using Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma.
Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide

Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Speci Clinical Trial using allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- An Evaluation of the Toxicity and Therapeutic Effects of Epstein-Barr Virus-Immune (EBV)-Immune T-Lymphocytes Derived From Normal HLA-Compatible or Haplotype-Matched Donor in the Treatment of EBV-Associated Lymphoproliferative Diseases or Malignancies and Patients With Detectable Circulating Levels of EBV DNA Who Are at High Risk for EBV-Associated Lymphoproliferative Diseases.
allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes

T Cell Non-Hodgkin Lymphoma Clinical Trial using High Dose Chemotherapy with Autologous Stem Cell Transplant Followed by Maintenance Therapy with Romidepsin

Memorial Sloan-Kettering Cancer Center - Recruiting 16 years or older.
- A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma.
High Dose Chemotherapy with Autologous Stem Cell Transplant Followed by Maintenance Therapy with Romidepsin

Leukemia Clinical Trial using Daunorubicin; Vincristine; Prednisone; PEG-Asparaginase; Methotrexate; 6-MP (6-Mercaptopurine); Cyclophosphamide; Cytarabine; Leucovorin; Dexamethasone

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years to 60 years.
- A Novel 'Pediatric-Inspired' Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia.
Daunorubicin; Vincristine; Prednisone; PEG-Asparaginase; Methotrexate; 6-MP (6-Mercaptopurine); Cyclophosphamide; Cytarabine; Leucovorin; Dexamethasone

Non-Small Cell Lung Cancer Clinical Trial using Cabozantinib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer.
Cabozantinib

Advanced Lung Cancer Clinical Trial using Ganetespib (STA-9090) and crizotinib

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase I/II Study of Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers.
Ganetespib (STA-9090) and crizotinib

Myelodysplastic Syndromes (MDS), or Acute Myelogenous Leukemia (A Clinical Trial using low dose 5'-azacitidine

Memorial Sloan-Kettering Cancer Center - Recruiting 1 year to 75 years.
- A Single Arm Phase II Trial of Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse.
low dose 5'-azacitidine

Inpatients With Limited English Proficiency Clinical Trial using Patient Survey; Provider Survey

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC.
Patient Survey; Provider Survey

Brain and Central Nervous System Tumors, Intraocular Melanoma, Lu Clinical Trial using DNA analysis; immunologic technique; pharmacological study; iodine I 131 monoclonal antibody 3F8; 131I-3F8

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms.
DNA analysis; immunologic technique; pharmacological study; iodine I 131 monoclonal antibody 3F8; 131I-3F8

Esophageal Cancer, or Gastric Cancer Clinical Trial using Afatinib (BIBW 2992)

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Afatinib (BIBW 2992) in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer.
Afatinib (BIBW 2992)

Rectal Cancer Clinical Trial using Advanced MR Imaging

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- Pilot Study of Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer.
Advanced MR Imaging

Melanoma Clinical Trial using Dabrafenib

Memorial Sloan-Kettering Cancer Center - Recruiting 16 years or older.
- A Phase 2 Trial of Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation.
Dabrafenib

Breast Cancer Clinical Trial using Verbal and Written Instruction; Verbal and Written Plus Simulation

Memorial Sloan-Kettering Cancer Center - Recruiting 19 years or older.
- A Comparison of Strategies for Injection Teaching: Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers.
Verbal and Written Instruction; Verbal and Written Plus Simulation

Breast Neoplasms, Ovarian Neoplasms, Colonic Neoplasms, Prostatic Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers.

Breast Cancer Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Clinical Significance of Germline BRCA Mutations.

Breast Cancer, Lobular Carcinoma, or Invasive Breast Cancer Clinical Trial using Tissue specimen

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ.
Tissue specimen

Esophageal Cancer Clinical Trial using wireless pulse oximeter (Wipox)

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- A Prospective Trial to Evaluate Whether Variations in Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy.
wireless pulse oximeter (Wipox)

Women at Increased Risk for Developing Breast Carcinoma Clinical Trial using Mammography (CESM) and MRI

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer.
Mammography (CESM) and MRI

Chronic Pulmonary Disorder Clinical Trial using breathing techniques; Self-Administered Baseline and Transition Dyspnea Indexes

Memorial Sloan-Kettering Cancer Center - Recruiting 19 years or older.
- Breath Training Exercise for the Reduction of Chronic Dyspnea: a Pilot Study.
breathing techniques; Self-Administered Baseline and Transition Dyspnea Indexes

Relapsed B-Cell Acute Lymphoblastic Leukemia Clinical Trial using leukapheresis or collection of PBMCs; cyclophosphamide; modified T cells

Memorial Sloan-Kettering Cancer Center - Recruiting N/A to 26 years.
- A Phase I Trial of Autologous T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia.
leukapheresis or collection of PBMCs; cyclophosphamide; modified T cells

Sarcoma Clinical Trial using Specimen protocol

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma.
Specimen protocol

Renal Cell Carcinoma Clinical Trial using everolimus and bevacizumab

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC).
everolimus and bevacizumab